HZ/su vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HZ/su vaccine, covering 2019-11-01 to 2019-11-01. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older [Phase 3]